ONKURE THERAPEUTICS, INC. Shareholders' Equity
ONKURE THERAPEUTICS, INC. (OKUR) had Shareholders' Equity of $172.11 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-04
- 2026-06-30: Stockholders' Equity Attributable to Parent $172.11M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $184.35M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $56.18M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $66.43M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $172.11M 10-Q · filed 2026-08-04 | |
| 2026-03-31 | $184.35M 10-Q · filed 2026-08-04 | |
| 2025-12-31 | $56.18M 10-Q · filed 2026-08-04 | |
| 2025-09-30 | $66.43M 10-Q · filed 2026-08-04 | |
| 2025-06-30 | $78.17M 10-Q · filed 2026-08-04 | |
| 2025-03-31 | $90.65M 10-Q · filed 2026-08-04 | |
| 2024-12-31 | $103.83M 10-Q · filed 2026-08-04 | |
| 2024-09-30 | -$135.05M 10-Q · filed 2025-11-06 | $74.02M 10-Q · filed 2024-11-07 |
| 2024-06-30 | -$123.58M 10-Q · filed 2025-11-06 | $76.87M 10-Q · filed 2024-08-13 |
| 2024-03-31 | -$111.26M 10-Q · filed 2025-11-06 | $81.24M 10-Q · filed 2024-05-07 |
| 2023-12-31 | -$101.84M 10-K · filed 2026-03-12 | $88.61M 10-K · filed 2024-03-28 |
| 2023-09-30 | $114.94M 10-Q · filed 2024-11-07 | |
| 2023-06-30 | $132.53M 10-Q · filed 2024-11-07 | |
| 2023-03-31 | $87.08M 10-Q · filed 2024-11-07 | |
| 2022-12-31 | -$54.42M 10-K · filed 2025-03-10 | $99.97M 10-K · filed 2023-03-27 |
| 2022-09-30 | $112.05M 10-Q · filed 2023-11-13 | |
| 2022-06-30 | $124.16M 10-Q · filed 2023-11-13 | |
| 2022-03-31 | $135.32M 10-Q · filed 2023-11-13 | |
| 2021-12-31 | $147.21M 10-K · filed 2024-03-28 | |
| 2021-09-30 | $156.21M 10-Q · filed 2022-11-08 | |
| 2021-06-30 | $167.55M 10-Q · filed 2022-11-08 | |
| 2021-03-31 | -$48.72M 10-Q · filed 2022-11-08 | |
| 2020-12-31 | -$42.12M 10-K · filed 2023-03-27 | |
| 2020-09-30 | -$36.00M 10-Q · filed 2021-11-12 | |
| 2020-06-30 | -$31.04M 10-Q · filed 2021-11-12 | |
| 2020-03-31 | -$27.43M 10-Q · filed 2021-11-12 | -$27.43M 10-Q · filed 2021-05-20 |
| 2019-12-31 | -$23.13M 10-K · filed 2022-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |